[go: up one dir, main page]

AU2002213830A1 - The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache - Google Patents

The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache

Info

Publication number
AU2002213830A1
AU2002213830A1 AU2002213830A AU1383002A AU2002213830A1 AU 2002213830 A1 AU2002213830 A1 AU 2002213830A1 AU 2002213830 A AU2002213830 A AU 2002213830A AU 1383002 A AU1383002 A AU 1383002A AU 2002213830 A1 AU2002213830 A1 AU 2002213830A1
Authority
AU
Australia
Prior art keywords
tension
treatment
reuptake inhibitors
noradrenaline reuptake
type headache
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213830A
Inventor
Lars Bendtsen
Rigmor Jensen
Jes Olesen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEAD EXPLORER AS
Original Assignee
Head Explorer ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Head Explorer ApS filed Critical Head Explorer ApS
Publication of AU2002213830A1 publication Critical patent/AU2002213830A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002213830A 2000-10-31 2001-10-29 The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache Abandoned AU2002213830A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200001638 2000-10-31
US24673600P 2000-11-09 2000-11-09
US60246736 2000-11-09
DKPA200001638 2000-11-10
PCT/DK2001/000717 WO2002036125A1 (en) 2000-10-31 2001-10-29 The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache

Publications (1)

Publication Number Publication Date
AU2002213830A1 true AU2002213830A1 (en) 2002-05-15

Family

ID=31984948

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213830A Abandoned AU2002213830A1 (en) 2000-10-31 2001-10-29 The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache

Country Status (4)

Country Link
US (1) US20040048860A1 (en)
EP (1) EP1333835A1 (en)
AU (1) AU2002213830A1 (en)
WO (1) WO2002036125A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
AP2006003771A0 (en) 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
CA2652035A1 (en) * 2006-05-12 2007-11-22 Pharma Mar, S.A. Anticancer treatments
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
EP1132082A1 (en) * 1996-11-05 2001-09-12 Head Explorer ApS Use of substances capable of blocking the production of glutamate for treating tension-type headache
KR20090087135A (en) * 1999-07-01 2009-08-14 파마시아 앤드 업존 캄파니 엘엘씨 Highly selective norepinephrine reuptake inhibitors and methods of using the same

Also Published As

Publication number Publication date
WO2002036125A1 (en) 2002-05-10
EP1333835A1 (en) 2003-08-13
US20040048860A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AP2003002857A0 (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors.
AU2001269939A1 (en) Methods for eliminating the formation of biofilm
AU2001258771A1 (en) -secretase inhibitors
AU2002340010A1 (en) Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
AU2001272852A1 (en) Composition for the treatment of migraine
MXPA03000694A (en) New use of lipase inhibitors.
AU2002361861A1 (en) SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF
AU2002367129A1 (en) Organ fibrosis inhibitors
PL369850A1 (en) Substituted indoles, method for production and use thereof for the inhibition of pain
AU2001293891A1 (en) New combination for the treatment of asthma
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002224550A1 (en) Corrosion inhibitors
AU2002213830A1 (en) The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache
AUPQ904100A0 (en) Method of encryption
AU2002305868A1 (en) Inhibitors of reggamma
MXPA03009210A (en) New process for the preparation of oxabispidines.
AU2003290363A1 (en) Therapeutic use of selective noradrenaline reuptake inhibitors
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
ZA200205471B (en) Use of IL-18 inhibitors.
AU2003227519A1 (en) The use of milnacipran for the treatment of tension-type headache
ZA200110325B (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same.
AU2002349003A1 (en) Substituted indoles, method for production and use thereof for the inhibition of pain
AU2002366617A1 (en) Device for treating headache
AU2002315020A1 (en) Method of transacting account statements
AU2001298065A1 (en) Process for the preparation of matrix metalloproteinase inhibitors